Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of neuroactive compounds and enzyme inhibitors. Its structure supports the design of molecules targeting central nervous system disorders due to the presence of fluorinated moieties and a chiral alcohol, which enhance metabolic stability and binding selectivity. Commonly employed in medicinal chemistry for optimizing pharmacokinetic properties in drug candidates. Also utilized in the preparation of protease inhibitors and receptor modulators where stereochemistry and fluorination play critical roles in activity.